Biomedical engineering applies fundamental engineering principles to the study of biology, medicine and health. Our undergraduate program provides a broad background in chemical, mechanical, materials science and electrical engineering, and it prepares students for careers in biomedical research with a quantitative engineering emphasis. It is also designed to provide students with sufficient coursework for advanced training at graduate, medical or physical therapy schools or in other allied health professions. Our graduate program builds upon the established biomedical research strength at the University and trains future generations of researchers and professionals who will play a key role in multi- and interdisciplinary teams that bridge the gap between engineering and the biological sciences.
BME grad student Keely Heinz has received the 2015 Laird Merit Fellowship that is given to one first year grad student in the College of Engineering each year to honor the memory of George W. Laird. Keely is currently pursuing her BME PhD in John Slater’s lab, researching the fabrication of biomimetic microfluidic hydrogel constructs for advanced cell culture platforms. Read more.
Jill Higginson and her team have received a 5-year educational grant from NIH to incorporate practical clinical design experience into UD’s Biomedical Engineering curriculum. The plan is to expand the BME interdisciplinary senior design program to include clinically motivated projects identified during previous clinical immersion experiences. Within the context of this design project, students will identify the significance of the unmet clinical need, determine the impact of finding a practical solution, outline the design constraints, and generate a working prototype as a solution to the unmet clinical need.
A paper co-authored by Emily Day, “miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma”, has been selected as the cover of an upcoming issue of Genes & Development. The paper identifies a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor. The researchers used nanoparticles called spherical nucleic acids to safely deliver miR-182 across the blood-brain/blood-tumor barriers to reach tumor cells where they directly suppressed multiple oncogenes at once, increasing cancer cell death, reducing tumor growth, and improving overall survival. This approach offers a novel strategy for therapeutic intervention in GBM.
BME grad student Jilian Melamed was awarded a National Defense Science and Engineering Graduate (NDSEG) Fellowship. Jilian’s PhD research involves developing a nanoparticle-based treatment to overcome the resistance of cancer cells to chemotherapy. Read more.
At a Healthcare Hackathon hosted by the College of Health Sciences, BME undergrads were among the four student teams who presented their ideas to a diverse audience of state officials, Christiana Care physicians, state medical reps and UD faculty and staff. Read more.